These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30458163)

  • 21. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disrupted cross-laminar cortical processing in β amyloid pathology precedes cell death.
    Lison H; Happel MF; Schneider F; Baldauf K; Kerbstat S; Seelbinder B; Schneeberg J; Zappe M; Goldschmidt J; Budinger E; Schröder UH; Ohl FW; Schilling S; Demuth HU; Scheich H; Reymann KG; Rönicke R
    Neurobiol Dis; 2014 Mar; 63():62-73. PubMed ID: 24291517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AβPP-Transgenic 2576 Mice Mimic Cell Type-Specific Aspects of Acetyl-CoA-Linked Metabolic Deficits in Alzheimer's Disease.
    Bielarczyk H; Jankowska-Kulawy A; Höfling C; Ronowska A; Gul-Hinc S; Roßner S; Schliebs R; Pawelczyk T; Szutowicz A
    J Alzheimers Dis; 2015; 48(4):1083-94. PubMed ID: 26402099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease.
    Walker JM; Dixit S; Saulsberry AC; May JM; Harrison FE
    Neurobiol Dis; 2017 Apr; 100():87-98. PubMed ID: 28108292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages.
    Lalande J; Halley H; Balayssac S; Gilard V; Déjean S; Martino R; Francés B; Lassalle JM; Malet-Martino M
    J Alzheimers Dis; 2014; 39(1):121-43. PubMed ID: 24145382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue plasminogen activator arrests Alzheimer's disease pathogenesis.
    Oh SB; Byun CJ; Yun JH; Jo DG; Carmeliet P; Koh JY; Lee JY
    Neurobiol Aging; 2014 Mar; 35(3):511-9. PubMed ID: 24126163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease.
    Grand'maison M; Zehntner SP; Ho MK; Hébert F; Wood A; Carbonell F; Zijdenbos AP; Hamel E; Bedell BJ
    Neurobiol Dis; 2013 Jun; 54():59-67. PubMed ID: 23454197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits.
    Yan L; Chen Y; Li W; Huang X; Badie H; Jian F; Huang T; Zhao Y; Cohen SN; Li L; Zhang YW; Luo H; Tu S; Xu H
    Sci Rep; 2016 Jan; 6():18668. PubMed ID: 26733416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.
    Marottoli FM; Katsumata Y; Koster KP; Thomas R; Fardo DW; Tai LM
    ASN Neuro; 2017; 9(4):1759091417719201. PubMed ID: 28707482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
    Evans CE; Miners JS; Piva G; Willis CL; Heard DM; Kidd EJ; Good MA; Kehoe PG
    Acta Neuropathol; 2020 Mar; 139(3):485-502. PubMed ID: 31982938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons.
    Zhang B; Veasey SC; Wood MA; Leng LZ; Kaminski C; Leight S; Abel T; Lee VM; Trojanowski JQ
    Am J Pathol; 2005 Nov; 167(5):1361-9. PubMed ID: 16251420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.